icotec

icotec is a Swiss medical device company focused on developing, manufacturing, and marketing innovative non-metallic implants for tumor treatment, particularly spinal tumors. The company is a leader in the market for non-metallic spinal implants made from its proprietary BlackArmor® material, a carbon-fiber-reinforced plastic composite that enhances cancer care and radiotherapy. The core product line features BlackArmor® implants, which are designed to be stable and radiolucent, allowing for clear imaging during CT and MRI scans. These implants improve treatment accuracy by enabling homogeneous radiation doses without interference. icotec has also received FDA clearance for using BlackArmor® implants in treating spinal infections in the United States, broadening their clinical applications. icotec collaborates with healthcare professionals, including neurosurgeons and orthopedic surgeons, to provide tailored implant solutions for complex spinal tumor cases. The company is committed to innovation and quality, ensuring high standards in its products and services while maintaining a patient-centered approach. With offices in Switzerland and the USA, icotec supports a global market presence.

• Employees 220
• Founded 1999
• Annual Revenue $6400000
• Total Funding $30000000